Comment on the comment of Dr. Daniel Present.
Chey
William Y
WY
Shah
Ashok N
AN
D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use*; D003093:Colitis, Ulcerative / Q000188:drug therapy*; D018849:Controlled Clinical Trials as Topic; D005765:Gastrointestinal Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D006801:Humans; D000069285:Infliximab
D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D000069285:Infliximab